Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease renal cell carcinoma
Comorbidity C0494165|liver metastases
Sentences 3
PubMedID- 24090151 Whether liver damage occurs in patients with liver metastases of renal cell carcinoma after sunitinib administration is not yet known.
PubMedID- 24061106 So it seems that when using lesion size for treatment assessment, a threshold of −10% instead of −30% is better at distinguishing responders from non-responders among patients with mrcc receiving targeted therapy.figure 1liver metastases in a patient with renal cell cancer (a) before and (b) after sunitinib therapy.
PubMedID- 23962746 Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.

Page: 1